<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03622606</url>
  </required_header>
  <id_info>
    <org_study_id>P17/07_R-LAST</org_study_id>
    <nct_id>NCT03622606</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes</brief_title>
  <acronym>R-LAST</acronym>
  <official_title>Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a bi-centric study whose main objective is the validation of a rapid screening test&#xD;
      for language disorders in the acute phase of right hemisphere stroke.&#xD;
&#xD;
      Primary objective&#xD;
&#xD;
      The main objective is the validation of a rapid language disorder screening tool that will be&#xD;
      used in the acute phase of right hemispheric stroke.&#xD;
&#xD;
      Secondary objectives&#xD;
&#xD;
      Secondary objectives are:&#xD;
&#xD;
        -  Characterize the &quot;atypical crossed aphasia&quot; since the acute phase of stroke with a large&#xD;
           cohort of patients , which, to our knowledge, has never been done.&#xD;
&#xD;
        -  Re-evaluate the number of patients with acute language disorder in right hemisphere&#xD;
           stroke.&#xD;
&#xD;
        -  Validate the use of R-LAST by different categories of carers&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The R-LAST (Right Language screening test) comprises 8 subtests and a total of 15 items.&#xD;
&#xD;
      Validation will focus on the internal validity (no ceiling or floor effect, no redundancy,&#xD;
      internal consistency), the external validity (against a &quot;gold standard&quot; in order to evaluate&#xD;
      its specificity and its sensitivity) and the interclass agreement of R-LAST. The median time&#xD;
      to administrate de scale will be calculated.&#xD;
&#xD;
      The investigators will validate the scale by administering it to 300 consecutive patients&#xD;
      within 24 hours after admission to our 2 stroke units (Centre Hospitalier de Versailles and&#xD;
      Centre hospitalier du sud francilien) and to 100 stabilized patients with and without&#xD;
      atypical crossed aphasia using the MEC-P evaluation as a reference.&#xD;
&#xD;
      Patients must be 100% right-handed (Edinburgh test), be of French mother tongue, have no&#xD;
      history of neurological disease, have no sensory disturbances (blindness, deafness) and no&#xD;
      mirror crossed aphasia detected by the LAST (minimum score of 14/15 with a loss point granted&#xD;
      for the &quot;automatic speech&quot; subtest, potentially stranded in right strokes)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2018</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score at R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Internal validation: no item will present effect floor, ceiling or of redundancy.&#xD;
Validation inter examiner: the score obtained to R-LAST is independent from the examiner.&#xD;
External validation: the patients detected by gold standard as presenting a speech difficulty bound to a right hemispherical lesion will also be him by R-LAST (no forgery negatives), and that the patients not presenting speech difficulty during the signing of these standard gold will obtain the maximum score to R-LAST (no forgery positive).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score at LAST A and B</measure>
    <time_frame>Day 1</time_frame>
    <description>Detect the patients presenting a right hemispherical AVC with crossed aphasia &quot;mirror&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of signing R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>To obtain an average time of signing which will have to be shorter than that of the standard gold used during the external validation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simplicity and convenience of R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Contains only a sheet printed in black and white and both sides (to avoid the semantic indications bound to the color of an item, and to simplify the reproduction).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual aspect of R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Presentation in &quot;portrait&quot; mode, so that patients presenting a neurovisual disorder of type héminégligence or héminanopsie controlatérale are not penalized</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Acute and subacute phase of right stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention will be the passation of Right Language Screening Test (R-LAST).&#xD;
Patients in acute phase of right hemispheric stroke will be used for the internal validation and the integrated reliability of the Right Language screening test.&#xD;
Patients in subacute phase of right hemispheric stroke will be used for the external validation of the Right Language screening test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Right Language screening test (R-LAST)</intervention_name>
    <description>Validation of the Right Language screening test in acute and subacute phase of right stroke</description>
    <arm_group_label>Acute and subacute phase of right stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients must be the age of majority&#xD;
&#xD;
          -  Patients with right hemispheric stroke in the acute phase (internal validation +&#xD;
             inter-examiner validation) or stabilization phase (external validation) confirmed by&#xD;
             MRI or CT when MRI contraindicated&#xD;
&#xD;
          -  Patient with no &quot;mirror&quot; crossed aphasia detected by the LAST procedure (A or B):&#xD;
             LAST&gt; 14&#xD;
&#xD;
          -  Patients who read the newsletter&#xD;
&#xD;
          -  Affiliation to a social security scheme&#xD;
&#xD;
        Criteria Exclusion:&#xD;
&#xD;
          -  Minor patients&#xD;
&#xD;
          -  No French speakers&#xD;
&#xD;
          -  Patients with a history of stroke&#xD;
&#xD;
          -  Patients with dementia&#xD;
&#xD;
          -  Patients with sensory impairment: deafness, blindness&#xD;
&#xD;
          -  Patient not 100% right handed in the Edinburgh questionnaire&#xD;
&#xD;
          -  Inability to answer the Edinburgh Laterality Questionnaire and absence of any person&#xD;
             to fill in the questionnaire.&#xD;
&#xD;
          -  Patient with a left-handed person in its family&#xD;
&#xD;
          -  Illiterate patients&#xD;
&#xD;
          -  Patient presenting a &quot;mirror&quot; crossed aphasia detected by LAST A or B (score&#xD;
             tolerated: 14/15 with error accepted to the automatic speech)&#xD;
&#xD;
          -  Inability to receive the information letter about the protocol and to read the&#xD;
             newsletter&#xD;
&#xD;
          -  Refusal of the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier SMADJA, Neurologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sud Francilien Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Constance FLAMAND-ROZE, NeuroScientist</last_name>
    <phone>0611561520</phone>
    <email>constance.flamand.roze@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>virginie chatagner, ProjectManager</last_name>
    <phone>01 39 23 97 76</phone>
    <email>vchatagner@ch-versailles.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constance FLAMAND-ROZE</last_name>
      <email>constance.flamand.roze@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Didier SMADJA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy REGNIER</last_name>
      <email>wregnier@ch-versailles.fr</email>
    </contact>
    <investigator>
      <last_name>Fernando PICO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Constance FLAMAND-ROZE</investigator_full_name>
    <investigator_title>Neurosciences doctor</investigator_title>
  </responsible_party>
  <keyword>Right hemispheric Stroke</keyword>
  <keyword>Crossed aphasia</keyword>
  <keyword>Acute phase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

